View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Acadia ACP101-302

Phase: III
Clinicaltrials.gov ID: NCT06173531

What is the goal of the study?

This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study comparing carbetocin nasal spray 3.2 mg TID with placebo (matched placebo nasal spray TID) in subjects with PWS.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Grace Kim
Study Team Member: ECR Endocrine Research, endocrineresearch@seattlechildrens.org